GlassScriptPhysician profile
Khalid Abozguia
NPI 1265773105
$73,037.62
in general payments reported to CMS, 2019-2025
23 companies · $21K in 2025
The $21K reported for 2025 was more than what 89% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,691 · 2022: $15K · 2023: $16K · 2024: $20K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $34K · Food and Beverage: $22K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $34,154.80 |
| Food and Beverage | $22,388.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $26,456.39 | 2021-2025 | Diamondtemp Bidirectional Ablation Catheter, Micra, Arctic Front Advance |
| Boston Scientific Corporation | $17,708.97 | 2021-2025 | Ingevity+, Farapulse, Emblem Mri S-Icd |
| Abbott Laboratories | $16,041.73 | 2021-2025 | Ensite, Ensite Precision, Aveir |
| Biosense Webster, INC. | $3,748.09 | 2022-2025 | Carto 3, Soundstar, Nuvision Ice Catheter |
| Philips North America LLC | $3,122.07 | 2022-2025 | (Bs2) Lm Undivided, (9520) Igt Devices Undivided, Lm Undivided |
| Medical Device Business Services, INC. | $1,901.75 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $778.50 | 2022-2025 | Lifevest |
| Cook Incorporated | $720.53 | 2023 | Evolution |
| Cook Medical LLC | $688.73 | 2022-2023 | Cook |
| Novartis Pharmaceuticals Corporation | $529.33 | 2021-2024 | |
| Kestra Medical Technology Services, INC. | $338.05 | 2024-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $251.87 | 2022-2023 | Farxiga, Brilinta |
| Impulse Dynamics (USA) INC. | $170.25 | 2022 | |
| Atricure, INC. | $147.34 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $113.36 | 2022-2023 | Camzyos |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $93.52 | 2023 | Impella |
| Davol INC. | $79.94 | 2023 | Arista Ah Flexitip |
| Janssen Pharmaceuticals, INC | $38.36 | 2022 | |
| Terumo Medical Corporation | $37.34 | 2022 | |
| Novo Nordisk INC | $22.70 | 2023 | Ozempic |
| Pfizer INC. | $20.95 | 2023 | |
| Vivaquant INC, Dba Rhythm Express | $16.38 | 2025 | Rhythm Express |
| Amgen INC. | $11.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Abozguia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.